Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gynecologic 1

Conditions

Vomiting 1Uterine Cervical Neoplasms 1Nasopharyngeal Neoplasms 1

Interventions

Polymerase Chain Reaction 2Gene Expression Profiling 2Counseling 2Bupropion 2pembrolizumab 1fosaprepitant 1Zinc Oxide 1Varenicline 1Tropisetron 1Tobacco Use Cessation Devices 1Temozolomide 1Taxes 1Ritonavir 1Radiotherapy 1Psychiatric Rehabilitation 1Peripheral Blood Stem Cell Transplantation 1Oxaliplatin 1Nicotine Replacement Therapy 1Nicotine 1Indinavir 1Immunohistochemistry 1Fluorescent Antibody Technique 1Flow Cytometry 1Filgrastim 1Early Intervention, Educational 1Docetaxel 1Dexamethasone 1Cisplatin 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Nasopharyngeal Neoplasms × Tropisetron × Gynecologic × Clear all
NCT05564286 2024-02-06

Triple Antiemetic Regimen for Chemoradiotherapy in Cervical Cancer or Nasopharyngeal Cancer

Shantou University Medical College

Phase 3 Completed
116 enrolled
GynecologicHead & Neck

Uterine Cervical Neoplasms, Nasopharyngeal Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡